Characteristic analysis of adverse reactions of histone deacetylase inhibitors based on WHO-VigiAccess
BackgroundThis study assessed the adverse drug reactions (ADRs) associated with HDAC inhibitors using the VigiAccess database maintained by the World Health Organization (WHO). Furthermore, it compared the ADR profiles of three different drugs to identify the one with the lowest individualized risk...
Saved in:
| Main Authors: | Tongnan Yin, Yuyu Liu, Chenwen Li, Xinran Feng, Yumeng Lin, Zhongyu Qu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1563797/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adverse event profile of lomustine and temozolomide: a descriptive analysis from WHO-VigiAccess
by: Hua Luo, et al.
Published: (2025-03-01) -
The real-world analysis of adverse events with azacitidine: a pharmacovigilance study based on the FAERS and WHO-VigiAccess databases
by: Zhaorui Wang, et al.
Published: (2025-03-01) -
Characteristic analysis of adverse reactions of finerenone: an in-depth analysis from WHO-VigiAccess
by: Hongxuan Fan, et al.
Published: (2025-08-01) -
A real-world study of adverse drug reactions of two isocitrate dehydrogenase inhibitor based on the US FDA adverse event reporting system and VigiAccess databases
by: Mengmeng Peng, et al.
Published: (2024-11-01) -
A real-world pharmacovigilance study of adverse drug reactions associated with lecanemab and aducanumab based on WHO-VigiAccess and FAERS databases
by: Haoxiang Hu, et al.
Published: (2025-04-01)